4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000139
Director sold 1,666 shares at $20.66 ($34,420)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-10-16 | Sale 10b5-1 | −1,666 | $20.66 | $34,420 | 128,039 | D: show line 1 in the form |
| Open-market sales · 1,666 sh · avg $20.66 · $34,420 | |||||||
Loading xslF345X05/wk-form4_1697661869.xml…